Search

everythinglearnresearchcommunity

for

Search:↓

FDA-approved low-level light/laser therapy devices can significantly increase hair density in people with pattern hair loss.

Direct-to-consumer teledermatology platforms have financial conflicts of interest and lack proper patient care and follow-up.

PRP treatments for hair loss need standard protocols to be reliable.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

Most sunscreens meet safety standards, but tanning products often don't.

Exosome-based therapies in dermatology show promise but face challenges in standardization, regulation, and safety.

FDA-cleared devices often fail to produce high-quality platelet-rich plasma consistently.

New technologies replicate human skin for testing without animals.

Low-level laser therapy is safe and can increase hair growth for male and female pattern hair loss.

Exosomes could improve skin and hair treatments, but more research and regulation are needed.

Testosterone therapy can safely and effectively treat symptoms like low libido and fatigue in women, especially after menopause.

The herbal hair oil effectively promotes hair growth, nourishes the scalp, and prevents dandruff.

Minoxidil 2% and 5% are common treatments for female pattern hair loss, with other options including anti-androgens, oral contraceptives, and hair transplantation.

Exosomes might be a promising new treatment for hair loss.

Choose FDA-cleared red light therapy devices and follow guidelines for safe use.

Propecia is a top non-surgical treatment for hair loss, especially when combined with hair transplants.

Lasers are FDA-approved for permanent hair reduction, not removal, and more research is needed to improve treatments.

Photographic imaging is crucial for documenting and managing hair loss, requiring careful preparation and standardization to be effective.

Povidone iodine reduced skin bacteria more than chlorhexidine gluconate, but neither met FDA reduction standards.

Pediatric dermatologists have varied preferences for treating alopecia areata in children, with no standard FDA-approved treatments and some using JAK inhibitors despite risks.

Lasers in hair transplantation show promise but are not yet standard, with current methods causing some side effects and needles still being preferred for creating recipient sites.

Minoxidil and finasteride are the main FDA-approved treatments for hair loss, with other methods showing promise but lacking strong evidence.

The U.S. FDA regulates cosmetics for appearance purposes, but not as strictly as some other countries.

Exosomes show promise in dermatology but need more research and FDA approval for clinical use.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Platelet-rich plasma therapy improves hair growth and health in androgenetic alopecia better than some FDA-approved treatments.

PRP speeds up healing with few side effects, but more research is needed to standardize its use.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

Mesotherapy is a minimally invasive treatment with potential benefits and risks, requiring standardized practices and further investigation.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.